Moat Ross 4
4 · Kiniksa Pharmaceuticals International, plc · Filed Sep 8, 2025
Insider Transaction Report
Form 4
Moat Ross
CHIEF COMMERCIAL OFFICER
Transactions
- Sale
Class A Ordinary Share
2025-09-04$35.31/sh−3,523$124,397→ 9,415 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on November 13, 2024.